Austar Lifesciences Limited (HKG:6118)

Hong Kong · Delayed Price · Currency is HKD

0.7350

+0.0050 (0.68%)

Sep 11, 2026, 9:31 AM HKT

Market Cap	376.75M -39.3%
Revenue (ttm)	1.86B +10.4%
Net Income	19.94M -50.9%
EPS	0.04 -50.9%
Shares Out	512.58M
PE Ratio	18.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.7500
Previous Close	0.7300
Day's Range	0.7350 - 0.7500
52-Week Range	0.6500 - 1.6000
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About Austar Lifesciences

Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. The company also offers clean utility equipment and chemical pharmaceutical preparation systems; bioprocess equipment and systems; clean room, automation control, ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1991

Employees 1,490

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6118

Full Company Profile

Financial Performance

In 2025, Austar Lifesciences's revenue was 1.53 billion, an increase of 2.02% compared to the previous year's 1.50 billion. Earnings were 33.81 million, an increase of 110.24%.

Financial numbers in CNY Financial Statements